Dr. Lal PathLabs Limited (BOM:539524)
India
· Delayed Price · Currency is INR 2,908.85
+33.00 (1.15%)
At close: Jun 20, 2025
Dr. Lal PathLabs Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Revenue | 24,614 | 22,266 | 20,169 | 20,874 | 15,813 | Upgrade
|
| Revenue Growth (YoY) | 10.54% | 10.40% | -3.38% | 32.01% | 18.86% | Upgrade
|
| Cost of Revenue | 10,373 | 9,476 | 8,920 | 9,198 | 7,047 | Upgrade
|
| Gross Profit | 14,241 | 12,790 | 11,249 | 11,676 | 8,765 | Upgrade
|
| Selling, General & Admin | 4,501 | 4,135 | 3,577 | 3,474 | 2,498 | Upgrade
|
| Other Operating Expenses | 2,717 | 2,528 | 2,769 | 2,569 | 1,895 | Upgrade
|
| Operating Expenses | 8,648 | 8,109 | 7,848 | 7,129 | 5,167 | Upgrade
|
| Operating Income | 5,593 | 4,681 | 3,402 | 4,547 | 3,598 | Upgrade
|
| Interest Expense | -223.05 | -293.59 | -375.3 | -301.71 | -159.95 | Upgrade
|
| Interest & Investment Income | 664.58 | 554.3 | 331.78 | 472.61 | 438.75 | Upgrade
|
| Other Non Operating Income (Expenses) | 22.35 | 1.24 | 1.02 | 1.27 | 16.52 | Upgrade
|
| EBT Excluding Unusual Items | 6,057 | 4,943 | 3,359 | 4,719 | 3,893 | Upgrade
|
| Gain (Loss) on Sale of Investments | 209.3 | 103.97 | 64.21 | 31.62 | 47.29 | Upgrade
|
| Gain (Loss) on Sale of Assets | -21.51 | -2.18 | 8.07 | -6 | -1.74 | Upgrade
|
| Other Unusual Items | 3.35 | 9.29 | 6.96 | 4.95 | 5.42 | Upgrade
|
| Pretax Income | 6,248 | 5,055 | 3,438 | 4,750 | 3,944 | Upgrade
|
| Income Tax Expense | 1,325 | 1,432 | 1,028 | 1,247 | 979.3 | Upgrade
|
| Earnings From Continuing Operations | 4,923 | 3,623 | 2,411 | 3,503 | 2,965 | Upgrade
|
| Minority Interest in Earnings | -51.14 | -45.58 | -22.29 | -54.58 | -48.58 | Upgrade
|
| Net Income | 4,871 | 3,577 | 2,388 | 3,448 | 2,916 | Upgrade
|
| Net Income to Common | 4,871 | 3,577 | 2,388 | 3,448 | 2,916 | Upgrade
|
| Net Income Growth | 36.17% | 49.78% | -30.73% | 18.25% | 29.07% | Upgrade
|
| Shares Outstanding (Basic) | 83 | 83 | 83 | 83 | 83 | Upgrade
|
| Shares Outstanding (Diluted) | 83 | 83 | 83 | 83 | 83 | Upgrade
|
| Shares Change (YoY) | 0.22% | 0.14% | 0.21% | 0.24% | 0.23% | Upgrade
|
| EPS (Basic) | 58.48 | 43.05 | 28.82 | 41.70 | 35.33 | Upgrade
|
| EPS (Diluted) | 58.40 | 42.98 | 28.74 | 41.57 | 35.25 | Upgrade
|
| EPS Growth | 35.88% | 49.55% | -30.86% | 17.93% | 28.79% | Upgrade
|
| Free Cash Flow | 5,246 | 4,842 | 4,195 | 3,526 | 3,626 | Upgrade
|
| Free Cash Flow Per Share | 62.89 | 58.17 | 50.47 | 42.51 | 43.82 | Upgrade
|
| Dividend Per Share | 24.000 | 24.000 | 12.000 | 12.000 | 20.000 | Upgrade
|
| Dividend Growth | - | 100.00% | - | -40.00% | 66.67% | Upgrade
|
| Gross Margin | 57.86% | 57.44% | 55.77% | 55.94% | 55.43% | Upgrade
|
| Operating Margin | 22.72% | 21.02% | 16.86% | 21.78% | 22.75% | Upgrade
|
| Profit Margin | 19.79% | 16.07% | 11.84% | 16.52% | 18.44% | Upgrade
|
| Free Cash Flow Margin | 21.31% | 21.74% | 20.80% | 16.89% | 22.93% | Upgrade
|
| EBITDA | 6,579 | 5,673 | 4,412 | 5,188 | 3,989 | Upgrade
|
| EBITDA Margin | 26.73% | 25.48% | 21.88% | 24.86% | 25.22% | Upgrade
|
| D&A For EBITDA | 986.35 | 991.13 | 1,011 | 641.4 | 390.94 | Upgrade
|
| EBIT | 5,593 | 4,681 | 3,402 | 4,547 | 3,598 | Upgrade
|
| EBIT Margin | 22.72% | 21.02% | 16.86% | 21.78% | 22.75% | Upgrade
|
| Effective Tax Rate | 21.21% | 28.32% | 29.88% | 26.25% | 24.83% | Upgrade
|
| Revenue as Reported | 25,548 | 22,958 | 20,586 | 21,400 | 16,326 | Upgrade
|
| Advertising Expenses | 778.41 | 733.49 | 507.8 | 367.64 | 307.21 | Upgrade
|
Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.